Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Market Analysis of Atorvastatin: Monopoly and Generic Drugs, Slides of Managerial Economics

An analysis of pfizer's monopoly on atorvastatin (lipitor) and the impact of generic drugs on the market. It discusses the hatch-waxman act, pricing strategies, and market power sources. It also includes questions for managerial economics students.

Typology: Slides

2013/2014

Uploaded on 02/01/2014

akriti
akriti 🇮🇳

4.4

(123)

130 documents

1 / 30

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
MONOPOLY
docsity.com
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e

Partial preview of the text

Download Market Analysis of Atorvastatin: Monopoly and Generic Drugs and more Slides Managerial Economics in PDF only on Docsity!

MONOPOLY

CASE: ATORVASTATIN(降膽固醇藥)BY

PFIZER

 Pfizer markets atorvastatin under the brand name “Lipitor”.  In 2010, Lipitor was Pfizer’s best-selling drug.  Even while protected by patent, Lipitor faced competition from other statins- particularly simvastatin.  The US patent on simvastatin, owned by Merck, expired in 2006, and Merck cut the price of Zocor, its branded simvastatin.  Pfizer’s US patent on atorvastatin expired in June 2011.

MANAGERIAL ECONOMICS

QUESTIONS

 Pfizer must decide how to manage the competition.  How much should it spend on advertising?  At what scale should Pfizer produce the branded drug?  How would generic production of atorvastatin affect the market for the ingredients in the production of the drug?

MARKET

 Pure (Perfect) competition – least freedom in

pricing

 Monopolistic competition

 Medical clinic

 Oligopoly

 Hospital  anti-virus software, microcomputer operating system

 Monopoly – single supplier of good or a

service with no close substitute: most freedom

in pricing

SOURCES OF MARKET POWER

 unique resources  human  natural  intellectual property  patent  Copyright  economies of scale / scope  product differentiation  government regulation

  • 50 50 70 130 150 250 0.4 0.8 1.2 1.4 1.6 2 demand (marginal benefit) marginal revenue Quantity (Million units a year)

MONOPOLY: MARGINAL REVENUE

AND PRICE

infra-marginal units

MONOPOLY: PROFIT MAXIMUM, I

Operate at scale where marginal revenue = marginal cost  Justification: If marginal revenue > marginal cost, sell more and increase profit. If marginal revenue < marginal cost, sell less and increase profit.

OPERATING SCALE:
PROFIT MAXIMUM

DEMAND CHANGE

Find new scale where marginal revenue = marginal cost  should change price  new scale and price depend on both new demand and costs

COST CHANGE

Find new scale where marginal revenue = marginal cost  change in MC --> should change price (but less than change in MC)  change in fixed cost --> should not change price or scale

ADVERTISING

 benefit of advertising -- increment in contribution margin  advertising elasticity = % increase in demand from 1% increase in advertising

ADVERTISING: PROFIT MAXIMUM

Profit-maximizing advertising/sales = incremental margin x advertising elasticity

  • incremental margin = (price - MC)

COKE VS PEPSI, NOV. 1999

 Coke  raised prices by 7%  increased advertising and other marketing  Pepsi  raised price by 6.9%  what about advertising?

ANSWER

 Pepsi should increase advertising expenditure for two reasons:  price increase --> increase in incremental margin;  Pepsi’s increase in advertising will attract some marginal consumers -- those who are brand- switchers, relatively less loyal to Pepsi/Coke; so Coke’s demand will be more sensitive to advertising (higher advertising elasticity)